News

September 28, 2023
2023 Inno Fire Awards, Top Funding Rounds: Novasenta
// Read More
August 5, 2022
Pharmtech Focus: Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
// Read More
August 1, 2022
Fierce Biotech Fundraising Tracker
// Read More
July 29, 2022
Pittsburgh Inno: Novasenta raises $40M in Series A financing
// Read More
July 29, 2022
Labiotech.eu: Biotech startup Novasenta raises $40M to advance novel cancer therapeutics
// Read More
July 29, 2022
Endpoints Exclusive: UPMC launches another biotech, rooted in the tumor microenvironment
// Read More
August 31, 2021
Next Pittsburgh: UPMC Enterprises invests $20 million in startup changing the way we fight cancer
// Read More
August 27, 2021
Pittsburgh Business Times: UPMC launches cancer drug development firm Novasenta
// Read More
August 25, 2021
Science Advisory Board: UPMC Launches Immunotherapy Company, Novasenta
// Read More
August 24, 2021
MedCity News: UPMC launches cancer drug discovery company
// Read More
August 24, 2021
Pittsburgh Post-Gazette: UPMC launches immunotherapies startup in South Oakland
// Read More
August 23, 2021
One News Page: UPMC launches cancer drug development firm Novasenta
// Read More
August 23, 2021
HIT Consultant: UPMC Launches Drug Discovery Company Novasenta
// Read More
August 23, 2021
India Education Diary: UPMC Launches Novasenta to Develop Targeted Immunotherapy Drugs for Cancer
// Read More